The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease

Background and objective The prevalence of non-alcoholic fatty liver disease (NAFLD) is 60% in patients with type 2 diabetes mellitus (T2DM). NAFLD can lead to non-alcoholic steatohepatitis (NASH), both of which are the leading causes of cirrhosis. This study was undertaken to evaluate whether empag...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokharel, Arbinda, KC, Sudhamshu, Thapa, Pukar, Karki, Niyanta, Shrestha, Rupesh, Jaishi, Bikash, Paudel, Mukesh S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394637/
https://www.ncbi.nlm.nih.gov/pubmed/34466320
http://dx.doi.org/10.7759/cureus.16687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394637/
https://www.ncbi.nlm.nih.gov/pubmed/34466320
http://dx.doi.org/10.7759/cureus.16687

Ejemplares similares